SCHEMBL6212334

SCHEMBL6212334

Cc1cc2cc(Nc3ncc(Br)c(NCCc4ccccn4)n3)ccc2[nH]1.O=C1Cc2cc(Nc3ncc(Br)c(NCCc4ccccn4)n3)ccc2N1.O=C1Cc2cc(Nc3nccc(NCCc4ccccn4)n3)ccc2N1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 15/20 0.64
PTK2B Q14289 13/20 0.64
IGF1R P08069 3/20 0.41
BCL6 P41182 2/20 0.41
AURKA O14965 2/20 0.41
FGFR1 P11362 2/20 0.41
KDR P35968 2/20 0.41
PLK4 O00444 1/20 0.41
PDPK1 O15530 1/20 0.41
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
ROCK2 O75116 1/20 0.41
STK16 O75716 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
CHEK2 O96017 1/20 0.41
NTRK1 P04629 1/20 0.41
PRKCG P05129 1/20 0.41
INSR P06213 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6211698 0.87 PTK2 (0.84) PTK2PTK2BIGF1RBCL6AURKA
SCHEMBL6214288 0.84 PTK2 (0.49) PTK2PTK2BIGF1RFGFR1KDR
SCHEMBL6213023 0.83 PTK2 (0.61) PTK2PTK2BIGF1RBCL6AURKA
SCHEMBL6275030 0.81 PTK2 (0.47) PTK2PTK2BIGF1RFGFR1KDR
SCHEMBL6209416 0.81 PTK2 (0.72) PTK2PTK2BIGF1RBCL6AURKA
SCHEMBL6214944 0.79 PTK2 (1.00) PTK2PTK2BIGF1RBCL6AURKA
SCHEMBL6211093 0.78 PTK2 (0.84) PTK2PTK2BIGF1RBCL6AURKA
SCHEMBL6211546 0.78 PTK2 (0.67) PTK2PTK2BIGF1RBCL6AURKA
SCHEMBL6212232 0.77 PTK2 (0.67) PTK2PTK2BIGF1RBCL6AURKA
SCHEMBL6210376 0.77 PTK2 (0.66) PTK2PTK2BIGF1RBCL6AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578732-A2 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH Pfizer Products Inc. (US) 2005-09-28 EP disclosed
WO-2004056786-A2 PYRIMIDINE DERIVATES FOR THE TREATMENT OF ABNORMAL CELL GROWTH PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed